Ann: MGC Derma - CannaGlobal Transaction Update, page-48

Any deal can fall through and it's not that MXC didn't think highly of their derma division, they just had too many irons in the fire. For a young & relatively small company they are aware they need to produce revenue and quickly so have prioritized their areas of focus to ensure maximum returns/growth are achieved. With the big money being in the pharma this is where this outcome is most likely to come from.

Also the sale of the derma division allows the company to benefit and generate revenue from it over coming years through sales of core ingredients + its equity share in CannaGlobal providing CG are successful in listing on the Canadian stock exchange & marketing the derma products.